Research Article

PCSK9 Expression in Epicardial Adipose Tissue: Molecular Association with Local Tissue Inflammation

Table 1

Demographic, anthropometric, clinical, and biochemical characteristics.

CVD ()CAGB+VR ()

Age (years), 66.00 (59.00-74.75), 68.50 (55.75-77.00)
Male gender (, %)60, 88.24%28, 87.50%
BMI, 27.80 (25.40-30.39), 26.00 (24.63-30.57)
WC (cm), 105.00 (102.00-116.00), 104.00 (102.00-110.80)
EAT thickness (mm), 8.00 (5.00-9.00), 7.00 (5.00-8.00)
Fasting glucose (mg/dL), 93.00 (81.75-107.00), 94.00 (79.00-103.00)
Fasting insulin (microU/mL), 8.15 (5.87-11.39), 8.68 (6.27-12.22)
HbA1c (%), 5.41 (4.93-6.04), 5.17 (4.06-5.76)
HOMA-IR, 1.57 (1.12-2.71), 1.61 (1.02-2.23)
Total cholesterol (mg/dL), 154.50 (134.50-179.80), 159.50 (132.80-182.80)
LDL-cholesterol (mg/dL), 83.80 (68.20-108.70), 92.20 (65.20-115.00)
HDL-cholesterol (mg/dL), 43.00 (33.50-53.00), 48.00 (40.00-103.00)
Triglycerides (mg/dL), 105.50 (74.00-152.50), 97.00 (43.00-122.00)
CRP (mg/dL), 0.30 (0.10-0.80), 0.20 (0.10-0.50)
ALT (U/L), 25.00 (15.00-39.00), 24.00 (15.00-32.00)
AST (U/L), 21.00 (16.00-39.00), 21.00 (16.00-31.00)
Smoking (, %)38, 55.88%15, 46.88%
Hypertension (, %)53, 77.94%25, 78.13%
History of cardiovascular diseases (, %)25, 36.76%11, 34.38%
Dyslipidemia (, %)46, 67.65%18, 56.25%
Diabetes (, %)17, 25.00%2, 6.25%
Aspirin (, %)48, 70.59%20, 62.50%
ACEI/ARB (, %)46, 67.64%23, 71.88%
Antidiabetic agents15, 22.07%2, 6.25%
β-Blockers (, %)39, 57.35%16, 50.00%
Calcium channel blockers (, %)15, 22.06%6, 18.75%
Statins (, %)46, 67.65%18, 56.25%

The table shows the main characteristics of the whole studied population (CVD: cardiovascular disease patients) and the subgroup of patients who underwent either CABG (coronary artery bypass grafting) or VR (valvular replacement). Data are expressed as , median (25th-75th percentiles) or number and proportions. ACEI: angiotensinogen-converting enzyme inhibitor; ALT: alanine aminotransferase; AST: aspartate aminotransferase; ARB: angiotensin receptor blockade; BMI: body mass index; CRP: C reactive protein; EAT: epicardial adipose tissue; HbA1c: glycated hemoglobin; HOMA-IR: homeostatic model assessment of insulin resistance; WC: waist circumference. .